PANCREATIC CANCER RESECTABLE
Clinical trials for PANCREATIC CANCER RESECTABLE explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER RESECTABLE trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER RESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Three-Pronged attack on tough pancreatic tumors before surgery
Disease control Not yet recruitingThis study is testing whether a combination of three types of drugs can help shrink tumors before surgery in people with high-risk or borderline operable pancreatic cancer. The treatment includes a targeted drug (surufatinib), an immunotherapy drug (toripalimab), and a standard c…
Matched conditions: PANCREATIC CANCER RESECTABLE
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for toughest pancreatic cancer: testing chemo first
Disease control Not yet recruitingThis study aims to find out if giving chemotherapy before surgery helps people with left-sided pancreatic cancer live longer compared to having surgery right away. It will involve 381 patients who are fit for both treatments. Patients will be randomly assigned to receive either c…
Matched conditions: PANCREATIC CANCER RESECTABLE
Phase: PHASE3 • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC